Pyrazinamide compatibility reconstitution and stability: Difference between revisions

Jump to navigation Jump to search
(Created page with "__NOTOC__ {{Pyrazinamide }} {{CMG}}; {{AE}} {{chetan}} <ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = PYRAZINAMIDE (PYRAZINAMIDE) TABLET [MIK...")
 
(No difference)

Latest revision as of 01:02, 4 January 2014

Pyrazinamide
PYRAZINAMIDE® FDA Package Insert
Description
Clinical Pharmacology
Indications and Usage
Contraindications
Warnings and Precautions
Adverse Reactions
Overdosage
Dosage and Administration
How Supplied

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Chetan Lokhande, M.B.B.S [2]



[1]


References

  1. "PYRAZINAMIDE (PYRAZINAMIDE) TABLET [MIKART, INC.]".

Adapted from the FDA Package Insert.